Graves' disease development during sizofiran treatment.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Internal medicine

• Publication date

  2002-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.41.977PMID 12487171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells

  2004cited by this paper
• Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma

  2001cited by this paper
• Painless thyroiditis induced by the cessation of betamethasone.

  2001cited by this paper
• Long-term treatment with interferon-β therapy for multiple sclerosis and occurrence of Graves’ disease

  2000cited by this paper
• Postpartum autoimmune thyroid syndrome.

  2000cited by this paper
• A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers.

  1999cited by this paper
• Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.

  1996cited by this paper
• Occurrence of Graves' disease during retreatment with interferon-alpha 2a for chronic hepatitis C.

  1995cited by this paper
• Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease.

  1993cited by this paper
• Clinical effect of sizofiran combined with irradiation in cervical cancer patients: a randomized controlled study. Cooperative Study Group on SPG for Gynecological Cancer.

  1992cited by this paper
• Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer

  1989cited by this paper
• Cytokine-related immunomodulating activities of an anti-tumor glucan, sizofiran (SPG).

  1989cited by this paper
• Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer: A randomized controlled study

  1986cited by this paper
• Five patients with iodine-induced hyperthyroidism.

  1984cited by this paper
• High prevalence of transient post-partum thyrotoxicosis and hypothyroidism.

  1982cited by this paper
• Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG).

  1982cited by this paper

• Current Awareness: Pharmacoepidemiology and Drug Safety

  2003cites this paper